-
Four-ring medicine antihypertensive drug approved clinical trial
Time of Update: 2020-05-13
If teal itist is successfully marketed, it will be a more competitive antihypertensive innovation, providing clinicians and patients with high blood pressure with better treatment options (Natural) Enter sina financial stock bar discussion
-
Shenzhen investment control to build 6 major industrial park to build Shenzhen "Zhongguancun"
Time of Update: 2020-05-13
Sketch Six parks each specialize skilled in Shenzhen Software Industry Base: located in Shenzhen Bay High-tech District South District, adjacent to Shenzhen Bay, Qianhai Shenzhen-Hong Kong Modern Services Cooperation Zone, Houhai Financial Headquarters Economic Center, 620,000 square meters of construction area, covering research and development office, apartments, commercial and other business esquires, is committed to software, information and supporting services and other related enterprises to provide development space and professional services.
-
Incubator situator sought after the "high-precision" platform
Time of Update: 2020-05-13
Bright Science and Technology News In the past two years, China's industry has developed at a high speed, and gradually entered the era of industrial segmentation In this trend , the "big and clutte
-
"Guizhou is becoming a place where China's health and pharmaceutical industry is focused"
Time of Update: 2020-05-13
Original title: " Guizhou is to become the China's health medicine industry focus on the of the " " guizhou is to become the China's health medicine industry focus a blessing "On Octo
-
Lianyungang pharmaceutical sector backbone enterprise growth lead the province
Time of Update: 2020-05-13
recently, in the first half of 2014, the operation of major industrial industries in Jiangsu Province was released, the pharmaceutical sector with a growth rate of 14.0% leading the province's ind
-
Meiyin Health "Bright Family Bottom" Admits Some Medical Practitioners Filing Sits Are Not Timely
Time of Update: 2020-05-13
(original title: Meiyin Health "Bright Family Bottom" admits that some medical practitioners do not file in a timely manner) Securities Times reporter Yu Runsheng compared to the strongly worded med
-
The 7th (2015) International Asia Summit on Biomedical Research and Innovation was held in Shanghai
Time of Update: 2020-05-13
Explore how China and Asia-Pacific countries- pharmaceutical enterprises - CRO, CMO companies, scientific research institutions can integrate research and development platform, improve antibody industrialization key technology breakthroughs, new drug technology patents and scientific and technological cooperation innovation model!
-
The development model of biopersonalized innovative medicine of so-yuan is recognized.
Time of Update: 2020-05-13
original title: Soyuan Biopersonalized Innovation Drug Development Model Is Recognized Biotechnology Siono Biopharmaceuticals (Hangzhou) Co., Ltd engaged in personalized new drug research and dev
-
First advanced cervical cancer immunotherapy approved by FDA
Time of Update: 2020-05-13
Fosun Pharmaceutical Subsidiary Chongqing Pharmaceutical Scoilol Tablets through the conformity evaluation of generic drugs June 11, Fosun Pharmaceuticals announced that its subsidiary Chongqing Pharmaceutical Sini received the State Drug Administration issued the "drug supplementary application approval" on the alfa osteothelial alcohol tablets, the drug successfully passed the generic drug consistency evaluation.
-
Fujian Province Launches Government Guidance Fund for Biology and New Medicine
Time of Update: 2020-05-13
on February 1, , the government- led fund for the first biological and new medicine sinatted by the government in , Fujian Province, , launched its at fuzhou The Fund comprised 300 million
-
National "creative drug incubation (Jilin) base" project through the national acceptance expert group on-site inspection
Time of Update: 2020-05-13
on August 6, , the national "Creating Drug Incubation ( Jilin ) Base" project undertaken by Jilin Province passed the on-site acceptance of the acceptance the expert group's Jilin Provi
-
Vein theory guides the research value of vascular lesions
Time of Update: 2020-05-13
"The Chinese-style solution to medical reform cannot be separated from Chinese medicine and its theory "Recently, at the 2nd International Congress of Chinese and Western Medicine in conjunction with
-
Awareness of intellectual property protection must be raised
Time of Update: 2020-05-13
With its own rise, china's pharmaceutical companies protect independent intellectual property rights have been put on the agenda. Data show that as of 2014, Hengrui had 209 patent applications f
-
Howson won the first prize of scientific and technological progress of the National Federation of Industry and Commerce for three consecutive years.
Time of Update: 2020-05-13
url:?div-1,id:0 Innovation achievement enterprise competitiveness Howson for three consecutive years won the first prize of the national Industry and Commerce Association science and technology
-
Healthcare: Pharmaceutical medical device industry upgrade in the hope of recommending 3 shares
Time of Update: 2020-05-13
On August 18, the State Council issued an announcement on the Opinions on the Review and Approval System for medical devices Pharmaceuticals and Medical Devices This is a comprehensive answer to t
-
The rise of the new city of modern pharmaceutical industry
Time of Update: 2020-05-13
China Pharmaceutical City initially formed the industrial agglomeration effect and park brand advantages the new city of modern pharmaceutical industry in the rise the pharmaceutical city bird's eye
-
Biopharmaceutical Enterprises Focus on Xiqing Development Zone, Common Word 2015 Industry Dream
Time of Update: 2020-05-13
In 2014, biopharmaceutical industry as a national policy development of emerging industries ushered in a peak of development As one of the three leading industries in the West Youth Development Zon
-
Huahai Pharmaceuticals Issues Clarification Announcement on the Shansatan Incident
Time of Update: 2020-05-13
recently, the detection of "toxic" impurities in the raw materials of the shatan, has become the focus of public opinion. Yesterday (July 24), in response to the "Shatan incident", Huahai Pharmaceut
-
How Sichuan Medicine Abandons "Inertness" and Embraces Innovation
Time of Update: 2020-05-13
This reporter Zhou Wei August 11, composed of 20 provincial CPPCC members, "our province's high-end medical equipment and drug production" research group first station into Kanghong Pharmaceuticals
-
Hengrui Pharmaceuticals: The company's sales expense rate is in the industry's middle level
Time of Update: 2020-05-13
Medical Network May 13 hearing recently, Liandu Lishui City, Zhejiang Province People's Court released a criminal verdict, Lishui Central Hospital disclosed the original anesthesiology Leimou bribery
